tirzepatide not hungry 1-week update on Tirzepatide/B12 for weight loss Why Am I Still Hungry

Both routes of administration produce similar weight loss outcomes when properly dosed, but the daily commitment of oral tirzepatide appeals to patients who prefer tablets over injections

Because we do not know, most doctors will say, its probably best to avoid

In Feb26, Hernexeos (zongertinib) received FDA accelerated approval for advanced HER2-mutant NSCLC, based on a 76% objective response rate (N=72) in the Beamion LUNG-1 study, following Breakthrough Therapy Designation and prior approval in August 2025

Rybelsus (oral semaglutide) dosing update Novo Nordisks FDA-approved oral GLP-1 therapy, Rybelsus , now comes in two formulations: Formulation R1 tablets: 3 mg, 7 mg, and 14 mg Formulation R2 tablets: 1.5mg, 4mg, and 9?mg Standard titration protocols: R1 : Start at 3mg daily (days 130), increase to 7mg (days 3160)

Education on the proper injection technique is crucial to ensure efficacy and minimize potential complications

4,6 Each of the antidepressants has varying effects on the CYP450 system as it relates to warfarin ( TABLE 1 )